One Result on the Screen

A 47-year-old comes in for a routine visit. No polyuria, no polydipsia, no unexplained weight loss, nothing that reads as classic hyperglycemia on the chart. A fasting venous plasma glucose comes back at 131 mg/dL. The reference decision point for diabetes is 126 mg/dL and above. The number is unambiguous. The diagnosis is not, at least not yet, from this one line alone.

That gap between a single flagged value and a defensible diagnosis is what the diagnostic criteria are built to close. Diabetes is diagnosed from a defined set of laboratory categories, each with its own reference threshold, its own specimen requirement, and its own blind spots. Absent unequivocal hyperglycemia, a diagnosis generally needs two abnormal results: two different tests abnormal the same day, or the same test abnormal on two separate occasions. One elevated fasting glucose is evidence, not, by itself, a diagnosis.

The same shift produced two more numbers worth noticing before any of this is settled. A point-of-care capillary glucose charted from triage read 142 mg/dL, drawn nonfasting. A different patient's A1c came back at 5.9%, inside the 5.7-6.4% prediabetes band, with a lab comment flagging possible hemoglobin variant interference. Neither number can be read the way the fasting glucose was just read: each carries its own specimen and validation conditions before it can support a diagnosis.

A single glucose or A1c value in isolation raises a question; it does not answer one.